Literature DB >> 32668208

Genetic Fate Mapping of Transient Cell Fate Reveals N-Cadherin Activity and Function in Tumor Metastasis.

Yan Li1, Zan Lv1, Shaohua Zhang1, Zhuo Wang2, Lingjuan He1, Muxue Tang1, Wenjuan Pu1, Huan Zhao1, Zhenqian Zhang1, Qihui Shi2, Dongqing Cai3, Mingfu Wu4, Guohong Hu5, Kathy O Lui6, Jing Feng7, M Angela Nieto8, Bin Zhou9.   

Abstract

Genetic lineage tracing unravels cell fate and plasticity in development, tissue homeostasis, and diseases. However, it remains technically challenging to trace temporary or transient cell fate, such as epithelial-to-mesenchymal transition (EMT) in tumor metastasis. Here, we generated a genetic fate-mapping system for temporally seamless tracing of transient cell fate. Highlighting its immediate application, we used it to study EMT gene activity from the local primary tumor to a distant metastatic site in vivo. In a spontaneous breast-to-lung metastasis model, we found that primary tumor cells activated vimentin and N-cadherin in situ, but only N-cadherin was activated and functionally required during metastasis. Tumor cells that have ever expressed N-cadherin constituted the majority of metastases in lungs, and functional deletion of N-cad significantly reduced metastasis. The seamless genetic recording system described here provides an alternative way for understanding transient cell fate and plasticity in biological processes.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EMT; N-cadherin; genetic fate mapping; lineage tracing; metastasis; tumor; vimentin

Mesh:

Substances:

Year:  2020        PMID: 32668208     DOI: 10.1016/j.devcel.2020.06.021

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  17 in total

Review 1.  Role of CD44 isoforms in epithelial-mesenchymal plasticity and metastasis.

Authors:  Mark Primeaux; Saiprasad Gowrikumar; Punita Dhawan
Journal:  Clin Exp Metastasis       Date:  2022-01-12       Impact factor: 5.150

2.  Lineage Tracing Methods to Study Mammary Epithelial Hierarchies In Vivo.

Authors:  Verónica Rodilla; Silvia Fre
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Deciphering functional tumor states at single-cell resolution.

Authors:  Rolando Vegliante; Ievgenia Pastushenko; Cédric Blanpain
Journal:  EMBO J       Date:  2021-12-17       Impact factor: 11.598

4.  Epithelial-to-Mesenchymal Transition Drives Invasiveness of Breast Cancer Brain Metastases.

Authors:  Andreia S Margarido; Rebeca Uceda-Castro; Kerstin Hahn; Roebi de Bruijn; Lennart Kester; Ingrid Hofland; Jeroen Lohuis; Danielle Seinstra; Annegien Broeks; Jos Jonkers; Marike L D Broekman; Pieter Wesseling; Claire Vennin; Miguel Vizoso; Jacco van Rheenen
Journal:  Cancers (Basel)       Date:  2022-06-25       Impact factor: 6.575

Review 5.  Dual recombinases-based genetic lineage tracing for stem cell research with enhanced precision.

Authors:  Hengwei Jin; Kuo Liu; Bin Zhou
Journal:  Sci China Life Sci       Date:  2021-04-09       Impact factor: 6.038

Review 6.  Linking EMT programmes to normal and neoplastic epithelial stem cells.

Authors:  Arthur W Lambert; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2021-02-05       Impact factor: 69.800

7.  Progression to Metastasis of Solid Cancer.

Authors:  Eldad Zacksenhaus; Sean E Egan
Journal:  Cancers (Basel)       Date:  2021-02-10       Impact factor: 6.639

Review 8.  Strategies for site-specific recombination with high efficiency and precise spatiotemporal resolution.

Authors:  Xueying Tian; Bin Zhou
Journal:  J Biol Chem       Date:  2021-03-04       Impact factor: 5.157

Review 9.  Epithelial-to-Mesenchymal Transition in the Light of Plasticity and Hybrid E/M States.

Authors:  Laura Bornes; Guillaume Belthier; Jacco van Rheenen
Journal:  J Clin Med       Date:  2021-05-29       Impact factor: 4.241

Review 10.  How Lineage Tracing Studies Can Unveil Tumor Heterogeneity in Breast Cancer.

Authors:  Elena Vinuesa-Pitarch; Daniel Ortega-Álvarez; Verónica Rodilla
Journal:  Biomedicines       Date:  2021-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.